![Emma Thomas-Jones](https://profiles-cardiff.imgix.net/attachments/8139?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Emma Thomas-Jones
(hi/ei)
- Siarad Cymraeg
- Ar gael fel goruchwyliwr ôl-raddedig
Timau a rolau for Emma Thomas-Jones
Cyfarwyddwr Treialon Heintio, Llid ac Imiwnedd a Phrif Gymrawd Ymchwil
Trosolwyg
Rwy'n Gyfarwyddwr yr Is-adran Treialon Heintiau, Llid ac Imiwnedd ac yn Brif Gymrawd Ymchwil yn y Ganolfan Ymchwil Treialon .
Mae fy meysydd ymchwil mewn heintiau cyffredin, biofarcwyr ar gyfer heintiau a sepsis. Rwy'n cynnal ymchwil sy'n seiliedig ar dystiolaeth sy'n profi effeithiolrwydd ymyriadau gyda'r nod o leihau ymwrthedd i wrthfiotigau.
Mae gen i wybodaeth a phrofiad helaeth mewn methodoleg treialon clinigol, cynnal treialon a llywodraethu ymchwil.
Cyhoeddiad
2026
- Barry, T. D. et al. 2026. National TB cohort review evaluation: insights for control strategies in low-incidence settings. IJTLD Open 3 (6), pp.396-402. (10.5588/ijtldopen.26.0678)
- Harding, C. et al., 2026. Diagnostic models for male lower urinary tract symptom management in primary care. British Journal of General Practice (10.3399/BJGP.2025.0513)
- Todd, S. et al., 2026. Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial. The Lancet Respiratory Medicine 14 (5), pp.417-431. (10.1016/S2213-2600(25)00433-3)
- Waldron, C. et al. 2026. MR-pro-adrenomedullin (MR-proADM) and host immune response biomarkers evaluation of procalcitonin-guided antibiotic duration in children with infection for stratification of effectiveness: the PRECISE study. Efficacy and Mechanism Evaluation 13 (4)(10.3310/GJEC0818)
- Lowe, J. et al. 2026. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a randomised placebo-controlled trial. Health Technology Assessment 30 (12)(10.3310/gjsk0401)
- Doughty, H. et al., 2026. Enhancing communication with bereaved relatives about emergency and critical care trials (ENHANCE): a mixed-methods study.. BMJ Open 16 (2) e106677. (10.1136/bmjopen-2025-106677)
- Prout, H. et al. 2026. Challenges in shared decision-making about major lower limb amputation: the PERCEIVE qualitative study. BMJ Open 16 e104407. (10.1136/bmjopen-2025-104407)
2025
- Euden, J. et al. 2025. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: the PEACH mixed methods study. Health Technology Assessment 29 (52), pp.1-32. (10.3310/GGFF9393)
- Henley, J. et al. 2025. Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sources. BMJ Open 15 e093210. (10.1136/bmjopen-2024-093210)
- Waldron, C. et al. 2025. Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT. Health Technology Assessment 29 (16)(10.3310/MBVA3675)
- Kalra, A. et al., 2025. Does the use of intravenous immunoglobulin improve clinical outcomes in adults with autoimmune encephalitis? A systematic review. Brain and Behavior 15 (5) e70491. (10.1002/brb3.70491)
- Waldron, C. et al. 2025. Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial. The Lancet Child & Adolescent Health 9 (2), pp.121-130. (10.1016/S2352-4642(24)00306-7)
- Varley, M. et al. 2025. Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.. BMJ Open 15 (1) e084345. (10.1136/bmjopen-2024-084345)
- Edwards, A. et al. 2025. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment 29 (1)(10.3310/RGTW5711)
2024
- Milosevic, S. et al. 2024. Rehabilitation experiences following major lower limb amputation due to complications of vascular disease: a UK qualitative study. Disability and Rehabilitation 46 (26), pp.6477-6486. (10.1080/09638288.2024.2329747)
- Barry, T. D. et al. 2024. The role of nurses in national TB control programs: qualitative insights from TB cohort review in Wales. Medical Research Archives 12 (12)(10.18103/mra.v12i12.6063)
- Sandoe, J. A. T. et al., 2024. A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19. Journal of Antimicrobial Chemotherapy 79 (11), pp.2792-2800. dkae246. (10.1093/jac/dkae246)
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 12 (8), pp.608-618. (10.1016/S2213-2600(24)00079-1)
- Webb, E. J. D. et al., 2024. The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study. Journal of Antimicrobial Chemotherapy 79 (8), pp.1831-1842. dkae167. (10.1093/jac/dkae167)
- Clark, A. et al., 2024. 6040 Validating the national PEWS and LqSOFA in general practice: a retrospective cohort study. Archives of Disease in Childhood , pp.A98.2-A99. (10.1136/archdischild-2024-rcpch.139)
- Clark, A. et al., 2024. Assessing acutely ill children in general practice using the National PEWS and LqSOFA clinical scores: a retrospective cohort study. British Journal of General Practice (10.3399/BJGP.2023.0638)
- Abel, K. et al., 2024. System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework. The Lancet Microbe 5 (5), pp.e500-e507. (10.1016/S2666-5247(24)00003-X)
- Webb, E. J. D. et al., 2024. Evidence of quality of life for hospitalised patients with COVID-19: a scoping review. Health Technology Assessment 29 (52), pp.33-56. (10.3310/ATPR4281)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190 (3), pp.382-391. (10.1093/bjd/ljad388)
- Gwilym, B. L. et al. 2024. Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study. BJS Open 8 (1) zrad135. (10.1093/bjsopen/zrad135)
2023
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27 30. (10.3310/HWNM2189)
- Henley, J. et al. 2023. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: Qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study). BMJ Open 13 (12) e077117. (10.1136/bmjopen-2023-077117)
- Leighton, P. et al., 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189 (3), pp.343-345. (10.1093/bjd/ljad152)
- Schoenbuchner, S. M. et al. 2023. Biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: statistical analysis plan for the BATCH trial and PRECISE sub-study. Trials 24 (1) 364. (10.1186/s13063-022-06956-9)
2022
- Gwilym, B. L. et al., 2022. Short-term risk prediction after major lower limb amputation: PERCEIVE study. BJS Open 109 (12), pp.1300-1311. (10.1093/bjs/znac309)
- Lenihan, R. A. F. et al., 2022. Mid-regional pro-adrenomedullin in combination with pediatric early warning scores for risk stratification of febrile children presenting to the emergency department: secondary analysis of a nonprespecified United Kingdom cohort study. Pediatric Critical Care Medicine 23 (12), pp.980-989. (10.1097/PCC.0000000000003075)
- Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients (PEACH): protocol for a retrospective observational study. Methods and Protocols 5 (6) 95. (10.3390/mps5060095)
- Chatoo, S. A. et al., 2022. Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in wave 1 versus wave 2: a systematic review. Presented at: BSAC Spring Conference 2022 10 - 11 May 2022. Vol. 4.Vol. S.2. (10.1093/jacamr/dlac053.012)
- Euden, J. et al. 2022. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial. BMJ Open 12 (6) e063424. (10.1136/bmjopen-2022-063424)
- Abbott, R. A. et al., 2022. Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and Experimental Dermatology 47 (5), pp.882-888. (10.1111/ced.15037)
- Totty, J. P. et al., 2022. Use of perioperative prophylactic antibiotics following excision of ulcerated skin lesions in the UK: a national, multispeciality survey of clinicians. Clinical and Experimental Dermatology 47 (5), pp.957-959. (10.1111/ced.15075)
- Gillespie, D. et al. 2022. Associations with post-consultation health-status in primary care managed acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2022 (17), pp.383-394. (10.2147/COPD.S340710)
- Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study. Presented at: Infection 2021: BSAC Winter Conference Virtual 9-10 December 2021. Vol. 4.Vol. 1. (10.1093/jacamr/dlac004.013)
- Allen, D. et al. 2022. Development, implementation and evaluation of an early warning system improvement programme for children in hospital: the PUMA mixed-methods study. Health and Social Care Delivery Research 10 (1)(10.3310/CHCK4556)
- Waldron, C. et al. 2022. Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open 12 (1) e047490. (10.1136/bmjopen-2020-047490)
- Milosevic, S. et al. 2022. PrEdiction of Risk and Communication of outcomE followIng major lower limb amputation: a collaboratiVE study (PERCEIVE)—protocol for the PERCEIVE qualitative study. BMJ Open 12 (1) e053159. (10.1136/bmjopen-2021-053159)
2021
- Milosevic, S. et al. 2021. Exploring patients’ experiences of analgesia after major lower limb amputation: A qualitative study. BMJ Open 11 e054618. (10.1136/bmjopen-2021-054618)
- Gwilym, B. L. et al., 2021. The PERCEIVE quantitative study: PrEdiction of Risk and Communication of outcome following major lower-limb amputation: protocol for a collaboratiVE study. BJS Open 5 (6) zrab118. (10.1093/bjsopen/zrab118)
- Richards, O. et al., 2021. Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS. Antibiotics 10 (11) 1425. (10.3390/antibiotics10111425)
- Phillips, R. et al., 2021. Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic. PLoS ONE 16 (10) e0258484. (10.1371/journal.pone.0258484)
- Milosevic, S. et al. 2021. Managing LUTS in primary care: qualitative study of GPs’ and patients’ experiences. British Journal of General Practice 71 (710), pp.e685-e692. (10.3399/BJGP.2020.1043)
- Preece, R. et al., 2021. A systematic review and narrative synthesis of risk prediction tools used to estimate mortality, morbidity, and other outcomes following major lower limb amputation. European Journal of Vascular and Endovascular Surgery 62 (1), pp.127-135. (10.1016/j.ejvs.2021.02.038)
- Milosevic, S. et al. 2021. Conducting invasive urodynamics in primary care: Qualitative interview study examining experiences of patients and healthcare professionals. Diagnostic and Prognostic Research 5 10. (10.1186/s41512-021-00100-y)
- Powell, N. et al., 2021. Use of procalcitonin during the first wave of COVID-19 in the acute NHS hospitals: a retrospective observational study. Antibiotics 10 (5) 516. (10.3390/antibiotics10050516)
- Gwilym, B. et al., 2021. PERCEIVE: PrEdiction of Risk and Communication of outcome following major lower limb amputation - a collaboratIVE study [Poster]. BJS Open 5 (Sup1), pp.i25. zrab032.089. (10.1093/bjsopen/zrab032.089)
2020
- Pell, B. et al. 2020. PRImary care Management of lower Urinary tract Symptoms in men: protocol for development and validation of a diagnostic and clinical decision support tool (the PriMUS study). BMJ 10 (6) e037634. (10.1136/bmjopen-2020-037634)
- Ambler, G. K. et al., 2020. Prognostic risk modelling for patients undergoing major lower limb amputation: an analysis of the UK National Vascular Registry. European Journal of Vascular and Endovascular Surgery 59 (4), pp.606-613. (10.1016/j.ejvs.2019.12.006)
2019
- Brookes-Howell, L. et al. 2019. Challenges in managing urinary tract infection and the potential of a point-of-care test guided care in primary care: an international qualitative study. BJGP Open 3 (2) 18X101630. (10.3399/bjgpopen18X101630)
2018
- Francis, N. A. et al. 2018. Oral steroids for hearing loss associated with otitis media with effusion in children aged 2 8 years: the OSTRICH RCT. Health Technology Assessment 22 (61)(10.3310/hta22610)
- Santer, M. et al., 2018. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT. Health Technology Assessment 22 (57)(10.3310/hta22570)
- Bosanquet, D. C. et al. 2018. Major lower limb amputation audit – introduction and implementation of a multimodal perioperative pain management guideline. British Journal of Pain 12 (4), pp.257-258. (10.1177/2049463718800736)
- Stuart, B. et al., 2018. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: Experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema). Trials 19 582.
- Francis, N. A. et al. 2018. Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial. Lancet 392 (10147), pp.557-568. (10.1016/S0140-6736(18)31490-9)
- Prout, H. C. et al. 2018. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials 19 419. (10.1186/s13063-018-2803-4)
- Gillespie, D. et al. 2018. Use of co-primary outcomes for trials of antimicrobial stewardship interventions. Lancet Infectious Diseases 18 (6), pp.595-597. (10.1016/S1473-3099(18)30289-5)
- Santer, M. et al., 2018. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ 361 k1332. (10.1136/bmj.k1332)
- Butler, C. C. et al. 2018. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice 68 (669), pp.e268-e278. (10.3399/bjgp18X695285)
- Ingram, J. et al. 2018. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study). Diabetic Medicine 35 (2), pp.255-261. (10.1111/dme.13431)
2017
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67 (665), pp.e830-e841. (10.3399/bjgp17X693641)
- Ambler, G. K. et al. 2017. Development of a core outcome set for studies involving patients undergoing major lower limb amputation for peripheral arterial disease: study protocol for a systematic review and identification of a core outcome set using a Delphi survey. Trials 18 (1) 628. (10.1186/s13063-017-2358-9)
- Bosanquet, D. C. et al., 2017. Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): study protocol for a randomised controlled pilot study. Trials 18 629. (10.1186/s13063-017-2357-x)
- Shepherd, V. et al. 2017. Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study). Trials 18 (1) 533. (10.1186/s13063-017-2284-x)
- Hollingworth, W. et al., 2017. The diagnosis of urinary tract infection in young children (DUTY) study clinical rule: economic evaluation. Value in Health 20 (4), pp.556-566. (10.1016/j.jval.2017.01.003)
- Francis, N. A. et al. 2017. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Annals of Family Medicine 15 (2), pp.124-130. (10.1370/afm.2038)
2016
- Glover, G. W. et al., 2016. Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data. Critical care (London, England) 20 (1) 381. (10.1186/s13054-016-1552-6)
- Francis, N. A. et al. 2016. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study. Health Technology Assessment 20 (19), pp.1-84. (10.3310/hta20190)
- Waldron, C. et al. 2016. Oral Steroids for the Resolution of Otitis Media with Effusion (OME) in Children (OSTRICH): study protocol for a randomised controlled trial. Trials 17 115. (10.1186/s13063-016-1236-1)
2015
- Gillespie, D. et al. 2015. Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residents. Age and Ageing 44 (5), pp.853-860. (10.1093/ageing/afv072)
- Butler, C. C. et al. 2015. Childhood urinary tract infection in primary care: a prospective observational study of prevalence, diagnosis, treatment, and recovery. British Journal of General Practice 65 (633), pp.e217-e223. (10.3399/bjgp15X684361)
2014
- Bates, J. et al., 2014. Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT (TM) informed management of uncomplicated UTI in primary care. BMC Family Practice 15 , pp.-. 187. (10.1186/s12875-014-0187-4)
2013
- Bates, J. et al., 2013. Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice. [Abstract]. Trials 14 (S1), pp.-. P10. (10.1186/1745-6215-14-S1-P10)
- Waldron, C. et al. 2013. Recruitment to diagnosis of urinary tract infections in young children (DUTY) study: an evaluation of the successful methods used in a primary care, prospective cohort study. [Abstract]. Trials 14 (S1), pp.-. P37. (10.1186/1745-6215-14-S1-P37)
2012
- Robling, M. R. et al. 2012. The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study). British Medical Journal 344 e2359. (10.1136/bmj.e2359)
2011
- Gregory, J. W. et al. 2011. Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: The DEPICTED study. Health Technology Assessment 15 (29), pp.1-202. (10.3310/hta15290)
Cynadleddau
- Chatoo, S. A. et al., 2022. Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in wave 1 versus wave 2: a systematic review. Presented at: BSAC Spring Conference 2022 10 - 11 May 2022. Vol. 4.Vol. S.2. (10.1093/jacamr/dlac053.012)
- Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study. Presented at: Infection 2021: BSAC Winter Conference Virtual 9-10 December 2021. Vol. 4.Vol. 1. (10.1093/jacamr/dlac004.013)
Erthyglau
- Barry, T. D. et al. 2026. National TB cohort review evaluation: insights for control strategies in low-incidence settings. IJTLD Open 3 (6), pp.396-402. (10.5588/ijtldopen.26.0678)
- Harding, C. et al., 2026. Diagnostic models for male lower urinary tract symptom management in primary care. British Journal of General Practice (10.3399/BJGP.2025.0513)
- Todd, S. et al., 2026. Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial. The Lancet Respiratory Medicine 14 (5), pp.417-431. (10.1016/S2213-2600(25)00433-3)
- Waldron, C. et al. 2026. MR-pro-adrenomedullin (MR-proADM) and host immune response biomarkers evaluation of procalcitonin-guided antibiotic duration in children with infection for stratification of effectiveness: the PRECISE study. Efficacy and Mechanism Evaluation 13 (4)(10.3310/GJEC0818)
- Lowe, J. et al. 2026. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a randomised placebo-controlled trial. Health Technology Assessment 30 (12)(10.3310/gjsk0401)
- Doughty, H. et al., 2026. Enhancing communication with bereaved relatives about emergency and critical care trials (ENHANCE): a mixed-methods study.. BMJ Open 16 (2) e106677. (10.1136/bmjopen-2025-106677)
- Prout, H. et al. 2026. Challenges in shared decision-making about major lower limb amputation: the PERCEIVE qualitative study. BMJ Open 16 e104407. (10.1136/bmjopen-2025-104407)
- Euden, J. et al. 2025. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: the PEACH mixed methods study. Health Technology Assessment 29 (52), pp.1-32. (10.3310/GGFF9393)
- Henley, J. et al. 2025. Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sources. BMJ Open 15 e093210. (10.1136/bmjopen-2024-093210)
- Waldron, C. et al. 2025. Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT. Health Technology Assessment 29 (16)(10.3310/MBVA3675)
- Kalra, A. et al., 2025. Does the use of intravenous immunoglobulin improve clinical outcomes in adults with autoimmune encephalitis? A systematic review. Brain and Behavior 15 (5) e70491. (10.1002/brb3.70491)
- Waldron, C. et al. 2025. Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial. The Lancet Child & Adolescent Health 9 (2), pp.121-130. (10.1016/S2352-4642(24)00306-7)
- Varley, M. et al. 2025. Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.. BMJ Open 15 (1) e084345. (10.1136/bmjopen-2024-084345)
- Edwards, A. et al. 2025. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment 29 (1)(10.3310/RGTW5711)
- Milosevic, S. et al. 2024. Rehabilitation experiences following major lower limb amputation due to complications of vascular disease: a UK qualitative study. Disability and Rehabilitation 46 (26), pp.6477-6486. (10.1080/09638288.2024.2329747)
- Barry, T. D. et al. 2024. The role of nurses in national TB control programs: qualitative insights from TB cohort review in Wales. Medical Research Archives 12 (12)(10.18103/mra.v12i12.6063)
- Sandoe, J. A. T. et al., 2024. A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19. Journal of Antimicrobial Chemotherapy 79 (11), pp.2792-2800. dkae246. (10.1093/jac/dkae246)
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 12 (8), pp.608-618. (10.1016/S2213-2600(24)00079-1)
- Webb, E. J. D. et al., 2024. The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study. Journal of Antimicrobial Chemotherapy 79 (8), pp.1831-1842. dkae167. (10.1093/jac/dkae167)
- Clark, A. et al., 2024. 6040 Validating the national PEWS and LqSOFA in general practice: a retrospective cohort study. Archives of Disease in Childhood , pp.A98.2-A99. (10.1136/archdischild-2024-rcpch.139)
- Clark, A. et al., 2024. Assessing acutely ill children in general practice using the National PEWS and LqSOFA clinical scores: a retrospective cohort study. British Journal of General Practice (10.3399/BJGP.2023.0638)
- Abel, K. et al., 2024. System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework. The Lancet Microbe 5 (5), pp.e500-e507. (10.1016/S2666-5247(24)00003-X)
- Webb, E. J. D. et al., 2024. Evidence of quality of life for hospitalised patients with COVID-19: a scoping review. Health Technology Assessment 29 (52), pp.33-56. (10.3310/ATPR4281)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190 (3), pp.382-391. (10.1093/bjd/ljad388)
- Gwilym, B. L. et al. 2024. Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study. BJS Open 8 (1) zrad135. (10.1093/bjsopen/zrad135)
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27 30. (10.3310/HWNM2189)
- Henley, J. et al. 2023. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: Qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study). BMJ Open 13 (12) e077117. (10.1136/bmjopen-2023-077117)
- Leighton, P. et al., 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189 (3), pp.343-345. (10.1093/bjd/ljad152)
- Schoenbuchner, S. M. et al. 2023. Biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: statistical analysis plan for the BATCH trial and PRECISE sub-study. Trials 24 (1) 364. (10.1186/s13063-022-06956-9)
- Gwilym, B. L. et al., 2022. Short-term risk prediction after major lower limb amputation: PERCEIVE study. BJS Open 109 (12), pp.1300-1311. (10.1093/bjs/znac309)
- Lenihan, R. A. F. et al., 2022. Mid-regional pro-adrenomedullin in combination with pediatric early warning scores for risk stratification of febrile children presenting to the emergency department: secondary analysis of a nonprespecified United Kingdom cohort study. Pediatric Critical Care Medicine 23 (12), pp.980-989. (10.1097/PCC.0000000000003075)
- Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients (PEACH): protocol for a retrospective observational study. Methods and Protocols 5 (6) 95. (10.3390/mps5060095)
- Euden, J. et al. 2022. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial. BMJ Open 12 (6) e063424. (10.1136/bmjopen-2022-063424)
- Abbott, R. A. et al., 2022. Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and Experimental Dermatology 47 (5), pp.882-888. (10.1111/ced.15037)
- Totty, J. P. et al., 2022. Use of perioperative prophylactic antibiotics following excision of ulcerated skin lesions in the UK: a national, multispeciality survey of clinicians. Clinical and Experimental Dermatology 47 (5), pp.957-959. (10.1111/ced.15075)
- Gillespie, D. et al. 2022. Associations with post-consultation health-status in primary care managed acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2022 (17), pp.383-394. (10.2147/COPD.S340710)
- Allen, D. et al. 2022. Development, implementation and evaluation of an early warning system improvement programme for children in hospital: the PUMA mixed-methods study. Health and Social Care Delivery Research 10 (1)(10.3310/CHCK4556)
- Waldron, C. et al. 2022. Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open 12 (1) e047490. (10.1136/bmjopen-2020-047490)
- Milosevic, S. et al. 2022. PrEdiction of Risk and Communication of outcomE followIng major lower limb amputation: a collaboratiVE study (PERCEIVE)—protocol for the PERCEIVE qualitative study. BMJ Open 12 (1) e053159. (10.1136/bmjopen-2021-053159)
- Milosevic, S. et al. 2021. Exploring patients’ experiences of analgesia after major lower limb amputation: A qualitative study. BMJ Open 11 e054618. (10.1136/bmjopen-2021-054618)
- Gwilym, B. L. et al., 2021. The PERCEIVE quantitative study: PrEdiction of Risk and Communication of outcome following major lower-limb amputation: protocol for a collaboratiVE study. BJS Open 5 (6) zrab118. (10.1093/bjsopen/zrab118)
- Richards, O. et al., 2021. Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS. Antibiotics 10 (11) 1425. (10.3390/antibiotics10111425)
- Phillips, R. et al., 2021. Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic. PLoS ONE 16 (10) e0258484. (10.1371/journal.pone.0258484)
- Milosevic, S. et al. 2021. Managing LUTS in primary care: qualitative study of GPs’ and patients’ experiences. British Journal of General Practice 71 (710), pp.e685-e692. (10.3399/BJGP.2020.1043)
- Preece, R. et al., 2021. A systematic review and narrative synthesis of risk prediction tools used to estimate mortality, morbidity, and other outcomes following major lower limb amputation. European Journal of Vascular and Endovascular Surgery 62 (1), pp.127-135. (10.1016/j.ejvs.2021.02.038)
- Milosevic, S. et al. 2021. Conducting invasive urodynamics in primary care: Qualitative interview study examining experiences of patients and healthcare professionals. Diagnostic and Prognostic Research 5 10. (10.1186/s41512-021-00100-y)
- Powell, N. et al., 2021. Use of procalcitonin during the first wave of COVID-19 in the acute NHS hospitals: a retrospective observational study. Antibiotics 10 (5) 516. (10.3390/antibiotics10050516)
- Gwilym, B. et al., 2021. PERCEIVE: PrEdiction of Risk and Communication of outcome following major lower limb amputation - a collaboratIVE study [Poster]. BJS Open 5 (Sup1), pp.i25. zrab032.089. (10.1093/bjsopen/zrab032.089)
- Pell, B. et al. 2020. PRImary care Management of lower Urinary tract Symptoms in men: protocol for development and validation of a diagnostic and clinical decision support tool (the PriMUS study). BMJ 10 (6) e037634. (10.1136/bmjopen-2020-037634)
- Ambler, G. K. et al., 2020. Prognostic risk modelling for patients undergoing major lower limb amputation: an analysis of the UK National Vascular Registry. European Journal of Vascular and Endovascular Surgery 59 (4), pp.606-613. (10.1016/j.ejvs.2019.12.006)
- Brookes-Howell, L. et al. 2019. Challenges in managing urinary tract infection and the potential of a point-of-care test guided care in primary care: an international qualitative study. BJGP Open 3 (2) 18X101630. (10.3399/bjgpopen18X101630)
- Francis, N. A. et al. 2018. Oral steroids for hearing loss associated with otitis media with effusion in children aged 2 8 years: the OSTRICH RCT. Health Technology Assessment 22 (61)(10.3310/hta22610)
- Santer, M. et al., 2018. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT. Health Technology Assessment 22 (57)(10.3310/hta22570)
- Bosanquet, D. C. et al. 2018. Major lower limb amputation audit – introduction and implementation of a multimodal perioperative pain management guideline. British Journal of Pain 12 (4), pp.257-258. (10.1177/2049463718800736)
- Stuart, B. et al., 2018. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: Experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema). Trials 19 582.
- Francis, N. A. et al. 2018. Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial. Lancet 392 (10147), pp.557-568. (10.1016/S0140-6736(18)31490-9)
- Prout, H. C. et al. 2018. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials 19 419. (10.1186/s13063-018-2803-4)
- Gillespie, D. et al. 2018. Use of co-primary outcomes for trials of antimicrobial stewardship interventions. Lancet Infectious Diseases 18 (6), pp.595-597. (10.1016/S1473-3099(18)30289-5)
- Santer, M. et al., 2018. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ 361 k1332. (10.1136/bmj.k1332)
- Butler, C. C. et al. 2018. Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice 68 (669), pp.e268-e278. (10.3399/bjgp18X695285)
- Ingram, J. et al. 2018. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study). Diabetic Medicine 35 (2), pp.255-261. (10.1111/dme.13431)
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67 (665), pp.e830-e841. (10.3399/bjgp17X693641)
- Ambler, G. K. et al. 2017. Development of a core outcome set for studies involving patients undergoing major lower limb amputation for peripheral arterial disease: study protocol for a systematic review and identification of a core outcome set using a Delphi survey. Trials 18 (1) 628. (10.1186/s13063-017-2358-9)
- Bosanquet, D. C. et al., 2017. Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): study protocol for a randomised controlled pilot study. Trials 18 629. (10.1186/s13063-017-2357-x)
- Shepherd, V. et al. 2017. Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study). Trials 18 (1) 533. (10.1186/s13063-017-2284-x)
- Hollingworth, W. et al., 2017. The diagnosis of urinary tract infection in young children (DUTY) study clinical rule: economic evaluation. Value in Health 20 (4), pp.556-566. (10.1016/j.jval.2017.01.003)
- Francis, N. A. et al. 2017. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Annals of Family Medicine 15 (2), pp.124-130. (10.1370/afm.2038)
- Glover, G. W. et al., 2016. Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data. Critical care (London, England) 20 (1) 381. (10.1186/s13054-016-1552-6)
- Francis, N. A. et al. 2016. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study. Health Technology Assessment 20 (19), pp.1-84. (10.3310/hta20190)
- Waldron, C. et al. 2016. Oral Steroids for the Resolution of Otitis Media with Effusion (OME) in Children (OSTRICH): study protocol for a randomised controlled trial. Trials 17 115. (10.1186/s13063-016-1236-1)
- Gillespie, D. et al. 2015. Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residents. Age and Ageing 44 (5), pp.853-860. (10.1093/ageing/afv072)
- Butler, C. C. et al. 2015. Childhood urinary tract infection in primary care: a prospective observational study of prevalence, diagnosis, treatment, and recovery. British Journal of General Practice 65 (633), pp.e217-e223. (10.3399/bjgp15X684361)
- Bates, J. et al., 2014. Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT (TM) informed management of uncomplicated UTI in primary care. BMC Family Practice 15 , pp.-. 187. (10.1186/s12875-014-0187-4)
- Bates, J. et al., 2013. Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice. [Abstract]. Trials 14 (S1), pp.-. P10. (10.1186/1745-6215-14-S1-P10)
- Waldron, C. et al. 2013. Recruitment to diagnosis of urinary tract infections in young children (DUTY) study: an evaluation of the successful methods used in a primary care, prospective cohort study. [Abstract]. Trials 14 (S1), pp.-. P37. (10.1186/1745-6215-14-S1-P37)
- Robling, M. R. et al. 2012. The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study). British Medical Journal 344 e2359. (10.1136/bmj.e2359)
- Gregory, J. W. et al. 2011. Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: The DEPICTED study. Health Technology Assessment 15 (29), pp.1-202. (10.3310/hta15290)
Ymchwil
Diddordebau Ymchwil
- Heintiau, Llid ac Imiwnedd
- Biofarcwyr a Dyfeisiau Pwynt Gofal
- Sepsis
- Stiwardiaeth gwrthficrobaidd
Grantiau
Rwyf wedi derbyn >£32miliwn mewn cyllid grant ar draws 24 grant, gan gynnwys £2miliwn fel cyd-brif ymchwilydd.
Grantiau ymchwil (mwyaf diweddar yn gyntaf), gyda fy rôl benodol yn feiddgar:
2024
- Abbott a Thomas-Jones, et al. EXamining antibiotics for ulCerated skIn cancer Surgical Excision (EXCISE). NIHR HTA. £1.5M (Cyd-Brif Ymchwilydd).
- Roberts, Roland, a Cathie et al. Treial ar hap o therapi mewnwythiennol aminophylline, magnesiwm sylffad neu salbutamol ar gyfer asthma difrifol acíwt mewn plant a phobl ifanc. NIHR HTA. £2.3M (Cyd-ymgeisydd, Arweinydd Rheoli Treialon).
2023
- Harding, et al. Paratoadau IntraVESical ar gyfer Atal Heintiau Tract Wrinol Ailadroddus (Treial VESPER): treial rhagoriaeth ar hap aml-fraich, aml-safle. NIHR HTA. £2.1M (Prif Ymchwilydd CTR)
- Kotecha, et al. Imiwnotherapi mwcosaidd bacteriol ar gyfer atal wheeze mewn babanod a anwyd yn gynamserol (Treial BALLOON). NIHR / MRC EME. £2.7M (Cyd-ymgeisydd).
- Pallmann P a Carrol E, et al. Gwerthusiad ar hap o ganlyniadau clinigol gan ddefnyddio technolegau newydd i optimeiddio therapi gwrthficrobaidd (PROTECT). NIHR HTA. £205K (Prif Ymchwilydd CTR).
2021
- Mark Tuthill et al. AMDDIFFYNIAD CYFLYM: treial clinigol addasol o frechu AZD7442 a SARS-CoV-2 mewn cleifion imiwnedd sy'n agored iawn i haint â firws SARS-CoV-2 AztraZeneca, £3.1M (prif ymchwilydd CTR).
2020
- Sandoe J a Carrol ED, et al. Procalcitonin: Gwerthusiad o ddefnydd o wrthfiotigau mewn cleifion COVID-19 yn yr ysbyty (Astudiaeth PEACH). Galwad Adferiad Cyflym COVID NIHR. £731,859. (Prif Ymchwilydd CTR)
- Phillips R, Thomas-Jones E, et al. Profiadau cyhoeddus COVID-19 yng Nghymru: Astudiaeth dulliau cymysg hydredol o agweddau, credoau ac ymddygiad mewn ymateb i'r pandemig coronafeirws (COPE Cymru). Galwad Ser Cymru am ymchwil COVID-19. £130K. (Cyd-brif Ymchwilydd).
- Bosanquet D, et al. PrEdiction of Risk and Communication of outcomE followingIng major lower coleg amputation – a collaboratiVE study (PERCEIVE). Health and Care Research Wales (Research for Patient and Public Benefit RfPPB), £229,225 (Cyd-ymgeisydd).
- Carrol ED, Thomas-Jones E, et al. - Gwerthusiad MR-Pro-adrenomedullin (MR-proADM) a ImmunoExpert o hyd gwrthfiotig dan arweiniad procalcitonin mewn Plant â Haint ar gyfer Haenu Effeithiolrwydd (PRECISE). Gwerthuso Effeithiolrwydd a Mecanwaith NIHR (EME). £385,451. (Cyd-Brif Ymchwilydd).
- Edwards AE, et al. Ymchwil Gofal Iechyd Cymru (Cyllid Seilwaith Llywodraeth Cymru). Adnewyddu seilwaith Canolfan PRIME. £4.8M (Cyd-ymgeisydd).
2019
- Hood K, et al. Ymchwil Iechyd a Gofal Cymru. Adnewyddu Seilwaith Ymchwil y Ganolfan Treialon. £2.5M (Cyd-ymgeisydd).
- Solomon T, et al. Enceph-IG - Imiwnoglobwlin Mewnwythiennol mewn Enseffalitis Awtoimiwnedd mewn Oedolion: Treial Rheoledig gan Placebo Dwbl-Dall ar Hap. NIHR / MRC EME. £2.4M (Prif Ymchwilydd CTR).
- Kotecha S, et al. AZithromycin ThErapy ar gyfer Clefyd Cronig yr ysgyfaint (AZTEC): Treial ar hap, a reolir gan placebo o azithromycin ar gyfer atal clefyd cronig yr ysgyfaint o gynamseroldeb mewn babanod cynamserol. NIHR HTA. £2,518,929. (Cyd-ymgeisydd).
- Ffrangeg N, et al. Gwerthusiad PROcalcitonin a NEWS ar gyfer Adnabod sepsis yn amserol a'r defnydd gorau posibl o wrthfiotigau yn yr Adran Achosion Brys (PRONTO). NIHR HTA. £1,964,286. (Prif Ymchwilydd CTR).
2018
- Ingram J, et al. Rheoli Hidrandenitis suppurativa (THESEUS). NIHR HTA. £629,000. (Prif Ymchwilydd CTR).
2017
- Carrol ED, et al. Cyfnod Triniaeth Gwrthfiotig mewn Plant sy'n cael eu hysbyty gyda haint bacteriol wedi'i gadarnhau neu a amheuir (BATCH). NIHR HTA. £1.5M. (Prif Ymchwilydd CTR).
- Edwards AE, Harding C. et al. Rheoli gofal sylfaenol symptomau'r llwybr wrinol isaf mewn dynion: Datblygu a dilysu cymorth diagnostig a gwneud penderfyniadau (PRIMUS). NIHR HTA. £1.6M. (Prif Ymchwilydd CTR).
2016
- Llinyn C, Bosanquet, D, et al. Treial clinigol cam II sy'n archwilio'r defnydd o gathetrau perineural ar ôl amputation aelodau isaf mawr mewn oedolion ag ischaemia aelodau critigol (Astudiaeth Dichonoldeb PLACE). Ymchwil Iechyd a Gofal Cymru (RfPPB). £210,552 (Prif Ymchwilydd CTR).
2015
· Cyllid Seilwaith Uned Treialon Clinigol. Ymchwil Iechyd a Gofal Cymru. £2.9 M. (Cyd-ymgeisydd).
2014
· Powell C, et al. System rhybuddio cynnar pediatrig (PEWS): Defnyddio ac Osgoi Marwolaethau (PUMA). Ymchwil Gwasanaeth Iechyd a Chyflenwi NIHR (HS&DR) £1.9 M. (Cyd-ymgeisydd).
2013
· Ingram J, et al. Cefnogi penderfyniadau rhagnodi gwrthfiotigau ar gyfer heintiau wlser traed diabetig: ymchwiliad i gywirdeb diagnostig biomarcwyr llidiol. Ymchwil Iechyd a Gofal Cymru RfPPB £195,920. (Cyd-ymgeisydd).
2011
· Butler C, et al. Steroidau Llafar ar gyfer Datrys otitis cyfryngau gydag effusion (OME) Mewn Plant (ESTRYS) NIHR HTA£ 1.3 M. (Cyd-ymgeisydd).
Bywgraffiad
Addysg a chymwysterau
- 1997: PhD "Amcangyfrif cyfaint plasma sy'n cylchredeg gan ddefnyddio starts hydroxyethyl wedi'i labelu'n fflwroleuol". Ysgol y Biowyddorau Moleciwlaidd a Meddygol, Prifysgol Cymru, Caerdydd.
- 1993: BSc mewn Biocemeg a Ffisioleg (Cyd-anrhydedd), Prifysgol Cymru, Coleg Caerdydd.
Trosolwg o'r gyrfa
- 2022 - presennol: Prif Gymrawd Ymchwil, Canolfan Ymchwil Treialon, Prifysgol Caerdydd.
- 2020 - presennol: Dirprwy Gyfarwyddwr Treialon Heintiau, Llid ac Imiwnedd, Canolfan Ymchwil Treialon, Prifysgol Caerdydd.
- 2019 - 2022: Uwch Gymrawd Ymchwil, Canolfan Ymchwil Treialon, Prifysgol Caerdydd.
- 2011 - 2019: Cymrawd Ymchwil (Uwch Reolwr Treial), Canolfan Ymchwil Treialon, Prifysgol Caerdydd.
- 2010 – 2011: Cymrawd Ymchwil Dros Dro (Uwch Reolwr Treialon), Uned Treialon De-ddwyrain Cymru, Prifysgol Caerdydd
- 2009 – 2010: Cydymaith Ymchwil (Rheolwr Treial), Uned Treialon De-ddwyrain Cymru, Prifysgol Caerdydd.
- 1999 – 2008: Uwch Wyddonydd, Technoleg Golau Moleciwlaidd (GenProbe Inc.), Caerdydd
- 1997 – 1999: Cydymaith Ymchwil, Ysgol y Biowyddorau, Prifysgol Cymru, Caerdydd.
Pwyllgorau Allanol
- Aelod presennol o fwrdd Pwyllgor Grant Rhaglen NIHR ar gyfer Ymchwil Gymhwysol
- Aelod blaenorol o fwrdd panel Ymchwil Iechyd a Gofal Cymru Ymchwil er Cleifion a Budd y Cyhoedd (RfPPB) (2018 i 2024)
- Aelod cyswllt blaenorol o fwrdd ar gyfer Pwyllgor Comisiynu HTA NIHR (2023-2024)
- Aelod annibynnol blaenorol ar gyfer sawl TSC
Aelodaethau proffesiynol
- Aelod o'r Gymdeithas Gofal Sylfaenol Academaidd (SAPC).
- Aelod o BSAC
Pwyllgorau ac adolygu
- Adolygydd grant ar gyfer Ymchwil Ymchwil Iechyd a Gofal Cymru ar gyfer Budd Cleifion a Chyhoeddus (RfPPB), Ysgol Ymchwil Gofal Sylfaenol NIHR.
- Adolygydd grant ar gyfer dyfarniadau cyllid MRC Hyder mewn Cysyniad a MRC Agosrwydd at Ddarganfod
- Aelod o Bwyllgor Ymchwil a Datblygu Cwm Taf
- Aelod o Bwyllgor Strategaeth Ymchwil Gofal Sylfaenol HCRW
- Aelod o'r pwyllgor llywio ar gyfer Fforwm Ymchwil Canolfan y De Orllewin
- adolygydd cyfnodolion ar gyfer BMJ, BMJ Open, British Journal of General Practice, Trials, a BMC Series (Clefydau Heintus, Ymarfer Teulu).
Meysydd goruchwyliaeth
Mae gen i ddiddordeb mewn goruchwylio myfyrwyr PhD ym meysydd:
- Biomarciwr dan arweiniad gwneud penderfyniadau gwrthficrobaidd
- ymwrthedd gwrthficrobaidd
- Methodoleg treialon clinigol
News articles
Contact Details
[email protected]
+44 29206 87520
Neuadd Meirionnydd, Llawr 7fed Llawr, Ystafell 708F, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4YS
+44 29206 87520
Neuadd Meirionnydd, Llawr 7fed Llawr, Ystafell 708F, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4YS
